• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2025 too short time to eliminate tuberculosis from India.

作者信息

Prasad Rajendra, Gupta Nikhil, Banka Amitabh

机构信息

Department of Pulmonary Medicine, Era's Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, India.

Department of Internal Medicine, Era's Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, India.

出版信息

Lung India. 2017 Sep-Oct;34(5):409-410. doi: 10.4103/lungindia.lungindia_186_17.

DOI:10.4103/lungindia.lungindia_186_17
PMID:28869222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5592749/
Abstract
摘要

相似文献

1
2025 too short time to eliminate tuberculosis from India.到2025年，印度根除结核病的时间太短。
Lung India. 2017 Sep-Oct;34(5):409-410. doi: 10.4103/lungindia.lungindia_186_17.
2
Indian government outlines plan to try to eliminate tuberculosis by 2020.印度政府概述了到2020年努力消除结核病的计划。
BMJ. 2014 Nov 3;349:g6604. doi: 10.1136/bmj.g6604.
3
No families affected by tuberculosis to face catastrophic costs by 2020: India's new strategic plan to eliminate tuberculosis.到2020年，印度消除结核病新战略计划：不让任何受结核病影响的家庭面临灾难性费用。
Indian J Tuberc. 2019 Apr;66(2):219-221. doi: 10.1016/j.ijtb.2019.04.009. Epub 2019 Apr 13.
4
What is New in Management of Pediatric Tuberculosis ?儿童结核病管理有哪些新进展？
Indian Pediatr. 2019 Mar 15;56(3):213-220.
5
Awareness about tuberculosis among nurses working in a tuberculosis hospital and in a general hospital in Delhi, India.印度新德里一家结核病医院和一家综合医院的护士对结核病的认知情况。
Int J Tuberc Lung Dis. 1998 Dec;2(12):1005-10.
6
How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India.结核病筛查价值几何？估算南非、中国和印度结核病主动病例发现的价值。
BMC Med. 2014 Oct 30;12:216. doi: 10.1186/s12916-014-0216-0.
7
Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay.通过分子信标分析法快速检测印度和墨西哥结核分枝杆菌分离株中的利福平耐药性。
J Clin Microbiol. 2004 Dec;42(12):5512-6. doi: 10.1128/JCM.42.12.5512-5516.2004.
8
Assessment of microbiological status after successful completion of intermittent revised national tuberculosis control programme directly observed treatment, short course regimen for microbiologically confirmed pulmonary tuberculosis cases: While new daily regimen going to be implemented in India.对微生物学确诊的肺结核病例成功完成国家结核病控制规划间歇修订短程直接观察治疗方案后的微生物学状况评估：鉴于印度即将实施新的每日用药方案。
Indian J Med Microbiol. 2018 Apr-Jun;36(2):251-256. doi: 10.4103/ijmm.IJMM_18_65.
9
BCG vaccination in India and tuberculosis in children: newer facets.印度的卡介苗接种与儿童结核病：新的方面
Indian J Pediatr. 1994 Sep-Oct;61(5):451-62. doi: 10.1007/BF02751703.
10
The status and prospects of tuberculosis control in India.印度结核病控制的现状与前景
Int J Tuberc Lung Dis. 2000 Mar;4(3):193-200.

引用本文的文献

1
Public-private partnership to end tuberculosis: challenges and opportunities.公私合作终结结核病：挑战与机遇
Int J Equity Health. 2025 Jul 4;24(1):195. doi: 10.1186/s12939-025-02516-0.
2
Review: missed tuberculosis cases in India: a systematic analysis of diagnostic, treatment, and reporting gaps.综述：印度未诊断出的结核病病例：对诊断、治疗及报告差距的系统分析
BMC Health Serv Res. 2025 Jul 1;25(1):858. doi: 10.1186/s12913-025-12967-4.
3
End Tuberculosis: Challenges and Opportunities.终结结核病：挑战与机遇
Tuberc Res Treat. 2024 Sep 4;2024:2307742. doi: 10.1155/2024/2307742. eCollection 2024.
4
Role of Ultrasound Acoustic Radiation Force Impulse in Differentiating Benign from Malignant Superficial Lymph Nodes.超声声辐射力脉冲在鉴别浅表淋巴结良恶性中的作用
J Clin Imaging Sci. 2020 Apr 6;10:18. doi: 10.25259/JCIS_175_2019. eCollection 2020.
5
In tuberculosis, "one size does not fit all".
Lung India. 2019 Jan-Feb;36(1):1-2. doi: 10.4103/lungindia.lungindia_489_18.

本文引用的文献

1
The Tuberculosis Cascade of Care in India's Public Sector: A Systematic Review and Meta-analysis.印度公共部门的结核病照护流程：一项系统评价与荟萃分析
PLoS Med. 2016 Oct 25;13(10):e1002149. doi: 10.1371/journal.pmed.1002149. eCollection 2016 Oct.
2
Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates.MDR 中的预广泛耐药和广泛耐药以及非 MDR 结核分枝杆菌分离株中的氧氟沙星和卡那霉素耐药。
Tuberculosis (Edinb). 2012 Sep;92(5):404-6. doi: 10.1016/j.tube.2012.05.010. Epub 2012 Jul 11.
3
Extensively drug-resistant Mycobacterium tuberculosis, India.广泛耐药结核分枝杆菌，印度。
Emerg Infect Dis. 2007 Sep;13(9):1429-31. doi: 10.3201/eid1309.070443.
4
Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience.现场耐多药结核病的管理：结核病研究中心的经验
Indian J Tuberc. 2007 Jul;54(3):117-24.
5
XDR tuberculosis in India: what's in a name?
Lancet Infect Dis. 2007 Jul;7(7):441-2. doi: 10.1016/S1473-3099(07)70141-X.